ICAHN CARL C
Managed by Carl Icahn · Portfolio as of Q2 2023
Top Holdings15 positions
ICAHN ENTERPRISES LP | 334.5M | $9.7B | 62.7% | $15.99 | -11.65% | 19 qtrssince 2018-Q4 | Increased 72 |
CVR ENERGY INC | 71.2M | $2.1B | 13.8% | $19.52 | +30.15% | 19 qtrssince 2018-Q4 | Unchanged 0 |
SOUTHWEST GAS HLDGS INC | 10.8M | $690.3M | 4.5% | $62.31 | -6.92% | 8 qtrssince 2021-Q3 | Increased 63 |
| 16.5M | $615.2M | 4.0% | — | — | — | Unchanged 0 | |
FIRSTENERGY CORP | 14.1M | $547.8M | 3.5% | $28.13 | +22.36% | 10 qtrssince 2021-Q1 | Decreased 0 |
XEROX HOLDINGS CORP | 34.2M | $509.9M | 3.3% | $14.95 | -12.54% | 6 qtrssince 2022-Q1 | Unchanged 0 |
BAUSCH HEALTH COS INC | 34.7M | $277.8M | 1.8% | $30.08 | -73.41% | 11 qtrssince 2020-Q4 | Unchanged 0 |
NEWELL BRANDS INC | 30M | $260.9M | 1.7% | $13.04 | -38.27% | 19 qtrssince 2018-Q4 | Unchanged 0 |
DANA INC | 14.3M | $242.9M | 1.6% | $20.31 | -23.29% | 11 qtrssince 2020-Q4 | Unchanged 0 |
CONDUENT INC | 38.1M | $129.7M | 0.8% | $9.55 | -63.79% | 19 qtrssince 2018-Q4 | Unchanged 0 |
CROWN HLDGS INC | 1M | $90.4M | 0.6% | $77.38 | +8.87% | 4 qtrssince 2022-Q3 | Unchanged 0 |
Illumina Inc | 430,000 | $80.6M | 0.5% | $226.22 | -19.38% | 2 qtrssince 2023-Q1 | Unchanged 0 |
SANDRIDGE ENERGY INC | 4.8M | $73.5M | 0.5% | $5.53 | +126.76% | 19 qtrssince 2018-Q4 | Unchanged 0 |
BAUSCH PLUS LOMB CORP | 3.5M | $70.2M | 0.5% | $15.24 | +31.69% | 5 qtrssince 2022-Q2 | Unchanged 0 |
INTERNATIONAL FLAVORS&FRAGRA | 644,510 | $51.3M | 0.3% | $116.34 | -36.73% | 6 qtrssince 2022-Q1 | Unchanged 0 |
ICAHN CARL C manages $15.5B across 15 positions as of Q2 2023. Top holdings: IEP (62.7%), CVI (13.8%), SWX (4.5%). Fund DNA: Concentrated Value. HoldingsIntel Score: 3.5/5.0.
Exited 2, increased 2, trimmed 1. Top move: IEP (INCREASED, conviction 72). Portfolio: $15.5B across 15 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR